3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
4606
Pancreatic Neoplasms
2845
Carcinoma, Hepatocellular
2480
Stomach Neoplasms
2330
Colonic Neoplasms
1791
Rectal Neoplasms
1720
Esophageal Neoplasms
1376
Liver Neoplasms
921
Neoplasms
915
Breast Neoplasms
839
Neoplasm Metastasis
765
Carcinoma, Non-Small-Cell Lung
707
Cholangiocarcinoma
587
Lung Neoplasms
557
Ovarian Neoplasms
535
Esophageal Squamous Cell Carcinoma
514
Gastrointestinal Neoplasms
495
Melanoma
381
Prostatic Neoplasms
373
Biliary Tract Neoplasms
373
Head and Neck Neoplasms
303
Uterine Cervical Neoplasms
288
Carcinoma, Renal Cell
284
Adenocarcinoma Of Esophagus
273
Squamous Cell Carcinoma of Head and Neck
264
Sarcoma
264
Gastrointestinal Stromal Tumors
252
Endometrial Neoplasms
235
Urinary Bladder Neoplasms
226
Gallbladder Neoplasms
225
Interventions
toripalimab
2
Oxaliplatin
2
Capecitabine
2
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Early Low Rectal Cancer
×
Gastrointestinal
×
Clear all
NCT05555888
2025-01-15
TORCH-E
Fudan University
Phase 2
Recruiting
34 enrolled
NCT06462053
2024-06-17
TORCH-E2
Fudan University
Phase 2
Recruiting
134 enrolled